1h Free Analyst Time
The regenerative medicine market is forecasted to grow by USD 125.82 billion during 2024-2029, accelerating at a CAGR of 28.1% during the forecast period. The report on the regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increasing support from public and private healthcare organizations, and increasing adoption of STEM cell therapy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The regenerative medicine market is segmented as below:
By Application
- Oncology
- Musculoskeletal
- Dermatology
- Others
By Technology
- Cell and tissue-based
- Gene therapy
By End-user
- Hospitals
- Clinics
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the regenerative medicine market covers the following areas:
- Regenerative Medicine Market sizing
- Regenerative Medicine Market forecast
- Regenerative Medicine Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Technology
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global regenerative medicine market: AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., MiMedx Group Inc., Novartis AG, NuVasive Inc., Organogenesis Holdings Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Baxter International Inc.
- Becton Dickinson and Co.
- Cook Group Inc.
- F. Hoffmann La Roche Ltd.
- Integra LifeSciences Holdings Corp.
- Johnson and Johnson
- Medtronic Plc
- Merck and Co. Inc.
- MiMedx Group Inc.
- Novartis AG
- NuVasive Inc.
- Organogenesis Holdings Inc.
- Smith and Nephew plc
- Thermo Fisher Scientific Inc.
- Vericel Corp.
- Zimmer Biomet Holdings Inc.
